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Abstract
Implantation is a complex spatio-temporal interaction between the growing embryo and the
mother, where both players need to be highly synchronized to be able to establish an effective
communication to ensure a successful pregnancy. Using our in vivo baboon model we have shown
that Chorionic Gonadotropin (CG), as the major trophoblast derived signal, not only rescues the
corpus luteum but also modulates the uterine environment in preparation for implantation. This
response is characterized by an alteration in both the morphological and biochemical activity in the
three major cell types: luminal and glandular epithelium and stromal fibroblasts. Furthermore, CG
and factors from the ovary have a synergistic effect on the receptive endometrium. Novel local
effects of CG which influence the immune system to permit the survival of the fetal allograft and
prevent endometrial cell death are also discussed in this review. An alternate extracellular signal-
regulated kinase (ERK) activation pathway observed in epithelial endometrial cells and the
possibility of differential expression of the CG/LH-R isoforms during gestation, open many
questions regarding the mechanism of action of CG and its signal transduction pathway within the
primate endometrium.
Review
One of the most important requirements for the mamma-
lian embryo to establish a successful pregnancy is its abil-
ity to implant in the mother's uterus. This process is a
highly coordinated series of events where the trophoblast
cells of the embryo establish contact with the uterus, to be
able to appose, attach to and intrude into the luminal epi-
thelium. Effectiveness of the implantation process implies
an appropriate spatio-temporal synchrony between the
maternal uterus and the growing embryo. The period
defined by this synchrony is called "window of receptiv-
ity". In the fertile human female, the period of receptivity
ranges from day 6 to day 10 post-ovulation (PO).
During the normal menstrual cycle the uterus undergoes
characteristic changes under the regulation of estrogen
and progesterone. In the baboon we have divided uterine
receptivity into three distinct phases. Phase I is regulated
by estrogen and progesterone and is evident between days
8 and 10 post-ovulation (PO) of the normal menstrual
cycle. Morphologically it is characterized by the presence
of columnar epithelium with microvilli and an increase in
stromal cells proliferation [1]. At the biochemical level,
there is a loss of estrogen receptor (ERα) and progesterone
receptor (PR) in the luminal and glandular epithelium
[2], together with a marked reduction of the polymorphic
mucin, Muc-1 expression [3]. Coincident with the
decrease in Muc-1 staining, there is an increase in smooth
muscle myosin II (SMM II) expression in the luminal and
glandular epithelium [6] and the appearance of pinopod-
like structures on the surface epithelium, similar to those
reported in the human [5].
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The second phase (Phase II) of uterine receptivity is
induced by blastocyst "signals" (ie., CG) superimposed
on the estrogen/progesterone primed receptive
endometrium. This phase is associated with functional
and morphological changes in the endometrium that are
distinct from those observed at a comparable time of a
non-pregnant cycle (i.e., phase I of uterine receptivity).
The final phase (phase III) of uterine receptivity is initi-
ated following attachment and implantation. A universal
response is the significant increase in the permeability of
the subepithelial capillaries surrounding the blastocyst
[6,7]. Together with glandular hypertrophy, stromal cell
decidualization is initiated and is accompanied by
increased secretion of extracellular matrix proteins.
Successful establishment of pregnancy requires an appro-
priately differentiated embryo concomitant with an
appropriately decidualized endometrium; tight regulation
of these processes appears to be essential. Many different
studies strongly support the idea that embryo-derived fac-
tors influence endometrial receptivity and implantation
in primates. Studies in rhesus monkey showed that
endometrial physiology during midluteal phase in pres-
ence or absence of an embryo is clearly different [4].
Chorionic Gonadotropin (CG) is one of the earliest
embryonic products secreted by the primate embryo. In
addition, the LH/CG receptor (CG/LH-R) is also expressed
in the primate endometrium [8]. Thus, we have proposed
that CG, as the major trophoblast derived signal, modu-
lates the uterine environment during the window of
receptivity, in addition to ensuring that the corpus luteum
continues to secrete progesterone.
Molecular biology of CG
CG is a glycoprotein hormone that belongs to the same
family as follicle-stimulating hormone (FSH), luteinizing
hormone (LH), and thyroid stimulating hormone (TSH).
These hormones share a common α subunit, but each has
a unique β subunit. All these hormones are glycosylated,
and the sugar moieties are important functionally in the
initiation of post-receptor mechanism. The α subunit is a
polypeptide of 92 amino acids residues with two N-linked
oligosaccharides encoded by a single gene on chromo-
some 6q21.1-23 [9]. A variant form, free α subunit, is cre-
ated when additional carbohydrates are attached on the
molecule. This subunit is classically viewed as a compo-
nent part of the dimeric hormone that allows the β subu-
nit to form its functional state. However, there is evidence
that it might have a role as an independent hormone [10].
The β subunit is a polypeptide of 145 amino acids resi-
dues with two N-linked oligosaccharides and four O-
linked oligosaccharides. This subunit is encoded by the
clusters of genes on the same location as LH β gene on
chromosome 19q13.3. This gene cluster is composed of
six CG β genes, one CG β pseudogene, and one LH β gene.
DNA sequence studies demonstrate approximately 96%
identity between CG β and LH β genes, explaining the
similar biological properties of both. However the mech-
anism for controlling the expression of these two genes at
the promoter region is different [11]. CG β mRNA has
been detected in the human embryo by in situ hybridiza-
tion as early as the 6–8 cell stage [12].
Effect of CG on the uterus
It has been well documented that CG accomplishes
important functions in the endometrium and in the tro-
phoblast tissue during peri-implantation period. Many
authors have shown a role for CG in regulating differenti-
ation [13], endocrine functions [14], and invasive activity
in the trophoblast [15].
We have tested the effects of CG in vivo using our baboon
(Papio anubis) model. Infusion of CG into the uterine cav-
ity of cycling animals between day 6 to day 10 PO, which
mimics normal blastocyst transit, resulted in profound
changes in all three major cell types (luminal and glandu-
lar epithelium and stromal endometrial cells) within the
uterine endometrium [16].
The epithelial plaque, usually formed as an early maternal
response to pregnancy in the luminal epithelium, was evi-
dent. These plaque cells stained intensely for cytokeratin
and the proliferating cell nuclear antigen. This response is
characterized by hypertrophy of the surface epithelium
and cells in the neck glands that round up and form acinar
clusters [17,18]. The induction of the plaque response
requires a synergism between the ovary and the
endometrium in response to CG [16].
In contrast, CG effects on glandular transformation and
stromal cell differentiation are direct, and independent of
the ovary [16]. CG infusion induces a marked increase in
transcriptional and post-translational modulation of gly-
codelin on the glandular epithelium [16]. Synthesis of
glycodelin by the glandular epithelium parallels the rise
and decline of CG in the peripheral circulation [19]. The
primary effect of CG on stromal fibroblasts is the induc-
tion of α-smooth muscle actin (αSMA) [16]. We have sug-
gested that the induction of αSMA in stromal fibroblasts
occurs as a consequence of integrins on the stromal cell
membranes (that are also induced in response to CG)
binding to secreted extra cellular matrix (ECM) proteins
[20]. The interaction between integrins and the ECM
induces changes in the actin cytoskeleton that are thought
to be critical for signal transduction leading to cell trans-
formation of the glandular epithelium [21] and the
appearance of pinopod-like structures on the surface epi-
thelium, similar to those reported in the human [5].Reproductive Biology and Endocrinology 2004, 2:50 http://www.rbej.com/content/2/1/50
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As effects of CG are superimposed on a progesterone-
primed endometrium, we studied the inhibition of pro-
gesterone action in intact and ovariectomized baboons.
After five days of treatment with progesterone receptor
antagonists (PRa) the epithelial plaque reaction was
reduced,  αSMA expression in stromal fibroblasts was
completely inhibited, and PR and ERα reappearance was
induced in epithelial cells. However, expression of gly-
codelin in the glandular epithelium was not modified.
Ten days of treatment with the PRa had a similar effect on
αSMA, PR, and ERα, but it also inhibited glycodelin
expression in the glandular epithelium [22].
These results indicated that blocking the action of proges-
terone on the endometrium even for a short period of
time has a profound effect on the CG-induced response in
stromal fibroblasts. In contrast, the diminution of epithe-
lial function in the presence of an ovary requires pro-
longed inhibition of progesterone action, suggesting a
potential paracrine effect on the endometrium from the
CL in response to CG.
Differentiation of a stromal fibroblast to a decidualized
cell is essential for the maintenance of pregnancy in the
primate. As the human endometrium undergoes cyclical
changes during menstrual cycle in preparation for implan-
tation, an embryionic "signal" is responsible for rescuing
stromal fibroblasts from normal regression at the end of
each non-pregnant ovarian cycle.
Apoptosis was first described in the human endometrium
in 1975 [23] and later it was shown to be rare in the pro-
liferative endometrium, whereas increasing in secretory
tissue and peaking during menstrual phase [24]. The reg-
ulation of apoptosis in the receptive endometrium by
either maternal steroids or fetoplacental signals is not
completely understood. Our preliminary studies in the
baboon indicate that ceramide induced apoptosis of stro-
mal cells can be significantly inhibited by CG, and this
effect is enhanced in the presence of estrogen and proges-
terone [25]. Studies in the human, suggest that three
apoptosis related proteins (Bcl-2, Bcl-X and Bax) are regu-
lated by ovarian steroids [26]. Our studies in women dem-
onstrate that in vivo treatment with hCG or progesterone
significantly increased Bcl-2 in the late luteal phase [27].
Bcl-X was higher in the CG treated group compared to the
progesterone treated group while Bax was inhibited by
progesterone primarily [27]. Thus, these observations
coupled with the evidence that NOTCH-1 also inhibits
apoptosis [28] suggest that CG acts on stromal fibroblasts
during the window of uterine receptivity to inhibit apop-
tosis and enhance differentiation [25]. Activation of
NOTCH-1 provides a temporary survival signal during the
differentiation of many cells, including thymocytes [29],
murine erythroleukemia cells [28], murine and human
and keratinocytes [30]. We therefore hypothesize that
progesterone and CG by inducing NOTCH-1 act synergis-
tically to inhibit apoptosis by upregulating anti-apoptotic
genes.
On the other hand, considering that hCG regulates the
immune system by an unknown mechanism [31], we
recently cloned the baboon gene for Stromal Cell Protein
(SCP), and demonstrated its regulation by CG [32]. Since
SCP induces the expression of recombinant activating
gene (RAG 1 and 2), and activates T-cells [33], we propose
that CG induction of SCP plays an important role in influ-
encing the unique immune system within the uterus that
permits the survival of the fetal allograft.
CG receptor and signal transduction pathways
In primates, in a cycle in which conception occurs, CG
secreted from the trophoblast acts as an LH superagonist
[34] extending the lifespun of the corpus luteum to secrete
progesterone until the luteal-placental shift occurs. On the
other hand, the same trophoblast derived CG directly or
indirectly acts to modulate the receptive endometrium
and enhance the implantation process.
Multiple mRNA transcripts for CG/LH receptor (CG/LH-
R) have been detected in human gonadal tissues. In the
human ovary, 8.0-, 7.0-, and 4.5-kb transcripts were seen
with the 4.5-kb being predominant [35]. Extragonadal
CG/LH-R expression has been reported in reproductive
(uterus, placenta and decidua) [8] and several non repro-
ductive tissues [36-38]. Although much work has been
done aiming to clarify CG/LH-R expression regulation
and signal transduction in the endometrium, there are
still many unanswered questions. The structural and fuc-
tional properties of these extragonadal CG/LH-R, espe-
cially in the endometrium, are still controversial [10,39].
It is not yet clear which of the different isoforms of this
receptor are expressed in this tissue, and if there are differ-
ential expression patterns during the course of gestation.
However, these receptors are functional based on in vivo
experiments in baboons [16] and in vitro studies with
human endometrial cell lines [40].
CG/LH-R is a member of the sub-family of glycoprotein
hormone receptors within the superfamily of G protein-
coupled/ seven transmembrane domain receptors
(GPCR) [41]. The receptor is composed of 11 exons, and
the gene has been mapped on chromosome 2p21 [42,43].
Two structurally and functionally distinct domains com-
pose the receptor. The final 11th exon of the gene encodes
the entire carboxyl-terminal half of the receptor, including
all seven transmembrane helices, the three interconnect-
ing extracellular loops, the three interconnecting intracel-
lular loops and the cytoplasmic tail. This carboxyl half of
the receptor shares homology with other members of theReproductive Biology and Endocrinology 2004, 2:50 http://www.rbej.com/content/2/1/50
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superfamily of rhodopsin-like G protein-coupled recep-
tors. The first 10 exons of the LH/CG receptor gene encode
the extracellular N-terminal exodomain that contains a
number of leucine-rich repeat motifs likely to be involved
in protein-protein interactions.
Binding of CG to its receptor generates signal transduction
through the activation of the associated heterotrimeric G-
proteins. In gonadal tissues, as it is in the classical
response, after the binding of CG to the receptor there is
an increase in cAMP and a consequent activation of pro-
tein kinase A (PKA) upon activation of the adenylyl
cyclase (AC) pathway and an increase in the intracellular
calcium through inositol triphosphate (IP3)/ phospholi-
pase A2 (PLA A2) pathway. A possible activation of pro-
tein kinase C (PKC) through diacylglycerol (DAG) has
also been suggested [44]. Activation of GPCR also stimu-
lates the desensitization of the receptor resulting in the
decrease in cellular sensitivity to further stimulation by
the ligand [45].
Although in the ovary CG/LH-R uses the conventional sig-
nal transduction pathway used by the GPCR, this does not
appear to be the case in the endometrium. Experiments
done in our laboratory using a human endometrial epi-
thelial cell line (HES) and baboon epithelial endometrial
cells [46] showed that CG does not activate the AC-cAMP-
PKA pathway but it can rapidly induce phosphorylation
of the extracellular signal-regulated kinase (ERK 1/2) in a
PKA independent manner. This novel signal transduction
pathway is functional and leads to an increase in COX-2
mRNA and PGE2 production. These results suggest the
existence of a unique signal transduction pathway acti-
vated by CG in the endometrial epithelial cells. These
results maybe explained by the existence of an alternate
spliced isoform of the CG/LH-R [like FSH-R, 47] or by the
presence of a different AC isoforms or by competition for
overlapping effector sites with other G proteins [48].
Diverse extracellular stimuli have been shown to activate
ERK kinases through GPCRs via different signal transduc-
tion pathways in other systems [49].
Considering that CG regulates changes in cytoskeletal pro-
teins during "window of receptivity" and that ERK 1/2 is
involved in processes of proliferation, growth and differ-
entiation in different systems, ERK 1/2 may be an impor-
tant signal regulating these CG mediated events in the
endometrium. The human endometrium exhibits high
basal AC activity and it possesses the capacity for cAMP
production in response to PGE2, PGF2, forskolin, and iso-
proterenol. In addition endometrial AC has been shown
to be upregulated by ovarian steroids [50]. The absence of
a cAMP stimulatory response to CG stimulation maybe
explained by the role of cAMP in CG/LH-R desensitization
process [51] This alternate ERK activation pathway may
prevent desensitization in presence of a high concentra-
tion of CG in the uterus during implantation, and thereby
permit CG to continuously exert its response on the
endometrium in preparation for pregnancy.
In the endometrium, CG/LH-R like immunoreactivity has
been demonstrated in several species like pig [52], rat
[53], rabbit [54], monkey [16] and humans [8]. Recently,
Licht [55] has shown a cycle-dependent expression of full-
length human CG/LH-R in human endometrium. In tro-
phoblast tissues there is a selective expression of different
CG/LH-R isoforms during the course of trophoblast differ-
entiation [56]. This possibility may also exist in the
endometrium during the course of gestation.
Thus, many questions still remain with regard to the
mechanism of action of CG and its signal transduction
pathways within the endometrium. The availability of
many different models such as primary cell cultures and
endometrial cell lines should aid in the goal of clarifying
the effects of CG in the primate uterus during implanta-
tion.
Conclusions
Implantation is a complex spatio-temporal interaction
between the embryo and the mother, where both players
need to be highly synchronized to be able to establish an
effective communication to ensure a successful preg-
nancy. Although estrogen and progesterone have long
been believed to be essential for developing an appropri-
ate endometrial environment for blastocyst implantation,
it is now evident that CG plays an important role during
the early stages of pregnancy in the primate.
There is convincing evidence that CG has direct effects on
the uterine endometrium during the establishment of
pregnancy. The activation of unique signaling pathways
results in functional changes in both the epithelial and
stromal cells in the uterine endometrium. In addition, CG
induces the expression of specific genes in the stromal
fibroblasts that may be important in modulating both the
immune system and cell survival at the maternal-fetal
interface.
Although evidence for a direct action of CG on uterine tis-
sues is strong, characterization of the various isoforms of
the CG/LH-R and their role in activating alternate signal
transduction pathways remain to be elucidated. Since the
action of CG during implantation may be regulated by its
local concentration and bioactivity and its action on the
CG/LH-R, understanding the mechanism by which CG
regulates uterine function has potentially important
implications for reproductive biology and human fertility.Reproductive Biology and Endocrinology 2004, 2:50 http://www.rbej.com/content/2/1/50
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